There were an estimated 263 million cases reported by the World Health Organization in 2023, up from about 248 million cases ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

The antibody from Chicago-based Immunartes is designed to neutralize the immune-evasive mechanisms of Staphylococcus aureus.

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...

Shares of Tiziana Life Sciences rose after the company said it received positive results from its nasal anti-CD3 monoclonal antibody in traumatic spinal cord injury. The stock was up 5.3% to 84 cents ...

Benchmark analyst Robert Wasserman maintained a Buy rating on Immunoprecise Antibodies Ltd. (NASDAQ:IPA) with a price target ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Human populations that left Africa evolved quickly whereas Neanderthals stayed the same, according to an analysis of blood group systems.

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...

Panelists discuss how industry-provided patient support services can assist patients receiving bispecific antibodies, particularly in monitoring and follow-up care, and how these services can support ...